NAMI Advocacy Actions

NAMI works with policymakers to advance priority issues and ensure that the voice of people affected by mental illness is considered in policymaking. Read NAMI’s recent letters to federal leaders, submitted comments and testimony and other resources.

NAMI is committed to ensuring accessibility for people with disabilities. If you would like to request an accessible version of any document on this page, please email us.

Filter By:
Letter to Congressional Committee Leadership on Covid19 & Mental Health Funding
04/04/2022
Letter to Senate HELP and House E&C Committees, urging a prevention and early intervention set-aside in the Community Mental Health Services Block Grant (MHBG) as the committees reauthorize programs administered by SAMHSA.
Letter to House Bill Sponsors on Child & Adolescent Mental Health
04/04/2022
Letter to Representatives Schrier and Miller-Meeks, expressing support for the introduction of H.R. 7076, the Supporting Children’s Mental Health Care Access Act of 2022, which would reauthorize the Pediatric Mental Health Care Access Program at the Health Resources and Services Administration for five years and make program improvements.
Letter to Senate Bill Sponsors on Child & Adolescent Mental Health
04/04/2022
Letter to Senators Murphy and Cassidy, expressing support for the introduction of S. 3864, the Supporting Children’s Mental Health Care Access Act of 2022, which would reauthorize the Pediatric Mental Health Care Access Program at the Health Resources and Services Administration for five years and make program improvements.
Letter to Congressional Bill Sponsors on Medicare
04/02/2022
Letter to Congressional bill sponsors in support of H.R. 3173/S. 3018, The Improving Seniors Timely Access to Care Act, which would improve the prior authorization process in Medicare Advantage.
Letter to Congressional Committee Leadership on Medication Access
03/31/2022
Letter to Senate Finance Committee Chairman Wyden and Ranking Member Crapo, urging the Committee to include the Non-Opioids Prevent Addiction in the Nation (“NOPAIN”) Act (S. 586) in the mental health legislative package currently under development.
Letter to Congressional Committee Leadership on Research & Treatment Innovation
03/29/2022
Letter to Appropriations Committee leadership, requesting $3.75 billion for the Centers for Disease Control and Prevention’s National Center for Chronic Disease Prevention and Health Promotion.
Letter to the Surgeon General on Child and Adolescent Mental Health
03/22/2022
Letter to U.S. Surgeon General Murthy, asking for the creation and distribution of a public education campaign on social media usage targeted at youth, their parents, and guardians to raise public awareness of this issue informed by science.
Letter to the Biden Administration on Mental Health Funding
03/21/2022
Letter to White House Social Secretary Elizondo asking about observing Mental Health Awareness Month by lighting The White House green on May 1, 2022.
Letter to Congressional Bill Sponsors on Mental Health Workforce
03/18/2022
Letter to Senators Kaine and Young and Representatives Wild and McKinley, in thanks for championing H.R. 1667, the Dr. Lorna Breen Health Care Provider Protection Act, and ensuring its passage.
Statement on Health Coverage
03/09/2022
Statement on consensus health care reform principles, including affordability, accessibility, adequacy and comprehensiveness.
Displaying results 121-130 (of 282)
 <  9 - 10 - 11 - 12 - 13 - 14 - 15 - 16 - 17 - 18  >